Histone H2B, member S Antibody

Western Blot: Histone H2B, member S Antibody [NB100-56347]

Western Blot: Histone H2B, member S Antibody [NB100-56347] - Top: Analysis of Histone H2B in human PBMC lysate with this antibody. Bottom: Western blot analysis of fractionated Cos-7 cells using this antibody anti-Histone H2B. Cos-7 cells were fractionated into nuclear cytosolic/membrane fractions. Approximately 15 ug of each fraction was separated on SDS PAGE. Lane 1) Nuclear fraction Lane 2) Cytosolic/membrane fraction.

Western Blot: Histone H2B, member S Antibody [NB100-56347]

Western Blot: Histone H2B, member S Antibody [NB100-56347] - BAY-87-2243 inhibits nuclear HIF-1alpha protein expression. UT-SCC-5 tumors were treated either with BAY-87-2243 or carrier for 3, 5, or 7 days and were excised 24 h after end of treatment. Western blots of nuclear HIF-1alpha from different animals 3 days after BAY-87-2243 application. Quantification of western blots by densitometry relative to histone-H2B, means +/- SD. Image collected and cropped by CiteAb from the following publication (https://ro-journal.biomedcentral.com/articles/10.1186/1748-717X-9-207), licensed under a CC-BY license.

Western Blot: Histone H2B, member S Antibody [NB100-56347] -

BAY-87-2243 inhibits nuclear HIF-1 alpha protein expression. UT-SCC-5 tumors were treated either with BAY-87-2243 or carrier for 3, 5, or 7 days and were excised 24 h after end of treatment: a) immunohistochemistry, black arrows indicate the positive nuclear HIF-1 alpha staining, scale bar: 20 μm; b) western blots of nuclear HIF-1 alpha from different animals 3 days after BAY-87-2243 application; c) quantification of western blots by densitometry relative to histone-H2B, means ± SD.